Ipilimumab’s Anniversary with Sharon Belvin

On March 25, 2011, the U.S. FDA approved a new treatment for advanced melanoma: ipilimumab (Yervoy). This is the first FDA approval of a checkpoint blockade immunotherapy and opened the field for several new checkpoint inhibitors that are today saving lives. On the tenth anniversary of this approval, we spoke with Sharon Belvin, one of the first patients to be treated successfully with this immunotherapy.
 

MEET SHARON